Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-24 @ 11:37 PM
NCT ID:
NCT02123056
Eligibility Criteria:
Inclusion Criteria:
1. ≥1 syncopal spells in the year preceding enrollment,
2. ≥-2 points on the Calgary Syncope Symptom Score for Structurally Normal Hearts, and (C) Age ≥ 40 years.
Exclusion Criteria:
1. resting heart rate \<50 bpm or supine systolic blood pressure \<90 mm Hg in the absence of beta blockers or antihypertensive medications,
2. other causes of syncope, such as sick sinus syndrome, ventricular tachycardia, complete heart block, postural hypotension or hypersensitive carotid sinus syndrome,
3. an inability to give informed consent,
4. important valvular, coronary, myocardial or conduction abnormality,
5. hypertrophic cardiomyopathy or known or probable genetic arrhythmia
6. a contraindication to beta blockers such as asthma, insulin-dependent diabetes, severe depression, peripheral vascular disease, chronic obstructive pulmonary disease, or previous intolerance of beta blockers,
7. another clinical need for beta blockers which can not be met with other drugs,
8. a seizure disorder,
9. major chronic non-cardiovascular disease,
10. an implanted defibrillator,
11. Known hypersensitivity to metoprolol and derivatives.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT02123056
Study Brief:
Protocol Section:
NCT02123056